1.         Aokage, K., Yoshida, J., Hishida, T., Tsuboi, M., Saji, H., Okada, M., Suzuki, K., Watanabe, S., Asamura, H.: Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review. Jpn J Clin Oncol, 47(1), 7-11, 2016.

2.         Iwata, T., Yoshino, I., Yoshida, S., Ikeda, N., Tsuboi, M., Asato, Y., Katakami, N., Sakamoto, K., Yamashita, Y., Okami, J., Mitsudomi, T., Yamashita, M., Yokouchi, H., Okubo, K., Okada, M., Takenoyama, M., Chida, M., Tomii, K., Matsuura, M., Azuma, A., Iwasawa, T., Kuwano, K., Sakai, S., Hiroshima, K., Fukuoka, J., Yoshimura, K., Tada, H., Nakagawa, K., Nakanishi, Y.: A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study). Respir Res, 17(1), 90, 2016.

3.         Omasa, M., Date, H., Takamochi, K., Suzuki, K., Miyata, Y., Okada, M.: Completion lobectomy after radical segmentectomy for pulmonary malignancies. Asian Cardiovasc Thorac Ann., 24(5), 450-454, 2016.

4.         Hasegawa, S., Okada, M., Tanaka, F., Yamanaka, T., Soejima, T., Kamikonya, N., Tsujimura, T., Fukuoka, K., Yokoi, K., Nakano, T.: Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial). Int J Clin Oncol, 21(3), 523-530, 2016.

5.         Hihara, J., Hamai, Y., Emi, M., Murakami, Y., Kenjo, M., Nagata, Y., Okada, M.: Role of definitive chemoradiotherapy using docetaxel and 5-fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II study. Dis Esophagus, 29(8), 1115-1120, 2016.

6.         Kushitani, K., Amatya, VJ., Okada, Y., Katayama, Y., Mawas, AS., Miyata, Y., Okada, M., Inai, K., Kishimoto, T., Takeshima, Y. : Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma. Histopathology, 70(3), 375-384, 2016.

7.         Mimae, T., Suzuki, K., Tsuboi, M., Ikeda, N., Takamochi, K., Aokage, K., Shimada, Y., Miyata, Y., Okada, M. : Severity of lung fibrosis affects early surgical outcomes of lung cancer among patients with combined pulmonary fibrosis and emphysema. Medicine, 95(29), 2016.

8.         Misumi, K., Sun, Jiying., Kinomura, A., Miyata, Y., Okada, M., Tashiro, S. : Enhanced gefitinib-induced repression of the epidermal growth factor receptor pathway by ataxia telangiectasia-mutated kinase inhibition in non-small-cell lung cancer cells. Cancer Sci, 107(4), 444-451, 2016.

9.         Masumoto, N., Kadoya, T., Amioka, A., Kajitani, K., Shigematsu, H., Emi, A., Matsuura, K., Arihiro, K., Okada, M.: Evaluation of Malignancy Grade of Breast Cancer Using Perflubutane-Enhanced Ultrasonography. Ultrasound Med Biol, 42(5), 1049-1057, 2016.

10.     Shimada, Y., Suzuki, K., Okada, M., Nakayama, H., Ito, H., Mitsudomi, T., Saji, H., Takamochi, K., Kudo, Y., Hattori, A., Mimae, T., Aokage, K., Nishii, T., Tsuboi, M., Ikeda, N.: Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer. Interact Cardiovasc Thorac Surg, 23(6), 895-901, 2016.

11.     Takahashi, S., Murakami, Y., Imano, N., Kaneyasu, Y., Doi, Y., Kenjo, M., Kimura, T., Kadoya, T., Arihiro, K., Kataoka, T., Okada, M., Nagata, Y.: Long-term results after 12-year follow-up of patients treated with whole-breast and boost irradiation after breast-conserving surgery. Jpn J Radiol, 34(9), 595-604, 2016.

12.     Takeda, M., Yamanaka, T., Seto, T., Hayashi, H., Azuma, K., Okada, M., Sugawara, S., Daga, H., Hirashima, T., Yonesaka, K., Urata, Y., Murakami, H., Saito, H., Kubo, A., Sawa, T., Miyahara, E., Nogami, N., Nakagawa, K., Nakanishi, Y., Okamoto, I. : Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial. Cancer, 122(7), 1050-1059, 2016.

13.     Hamai, Y., Hihara, J., Emi, M., Furukawa, T., Yamakita, I., Kurokawa, T., Okada, M.: Ability of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography to Predict Outcomes of Neoadjuvant Chemoradiotherapy Followed by Surgical Treatment for Esophageal Squamous Cell Carcinoma. Ann Thorac Surg. 102: 1132-1139, 2016.

14.     Furukawa, T., Hamai, Y., Hihara, J., Emi, M., Yamakita, I., Ibuki, Y., Okada, M.: Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 23(12): 4086-4092, 2016.

15.     Sasada, S., Kodiara, M., Shimoi, T., Shimomura, A., Yunokawa, M., Yonemori, K., Shimizu, C., Fujiwara, Y., Tamura, K.: Ifosfamide and Etoposide Chemotherapy in the Treatment of Recurrent/Refractory Rhabdomyosarcoma in Adults. Anticancer Res 36: 2429-2432, 2016.

16.     Sasada. S., Miyata. Y., Mimae, T., Tsutani, Y., Mimura, T., Okada. M.: Application of Lepidic Component Predominance to Adjuvant Chemotherapy with Oral Fluoropyrimidines for Stage I Lung Adenocarcinoma. Clin lung Cancer 17: 443-440, 2016.

17.     Ito, M., Miyata, Y., Yoshiya, T., Tsutani, Y., Mimura, T., Murakami, S.1), Ito, H.2), Nakayama, H.2), Okada, M.(1) Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan. 2)　Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.): Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma. European Journal Cardiothorac Surgery. 2017 Feb 1;51(2):218-222.

18.     Ibuki, Y., Hamai, Y., Hihara, J., Taomoto, J., Furukawa, T., Yamakita, I., Okada, M.: Surgical Resection of Thoracic Esophageal Cancer with Interstitial Lung Disease: A Case Report. Hiroshima J Med Sci. 65:19-23, 2016.

19.     Ibuki, Y., Tsutani, Y., Miyata, Y., Nakayama, H., Okumura, S., Yoshimura, M., Okada, M.: Preoperative predictors of distant recurrence in patients with clinical stage IA lung adenocarcinoma undergoing complete resection. Jpn J Clin Oncol. 47(2):157-163, 2017.

20.     Tsubokawa, N., Harada, H., Taniyama, D., Uemura, T., Kuraoka, K., Yamashita, Y.: Epithelioid sarcoma-like hemangioendothelioma on the chest wall. Asian Cardiovasc Thorac Ann. 2016 Oct;24(8):814-817.

21.     Tsubokawa, N., Mimae, T., Miyata, Y., Sasada, S., Yoshiya, T., Kushitani, K., Takeshima, Y., Murakami, S., Yokose, T., Ito, H., Nakayama, H., Okada, M.: Prognostic significance of vascular invasion in intermediate-grade subtype of lung adenocarcinoma. Jpn J Clin Oncol. 2016 Aug 27. [Epub ahead of print]

22.     Amioka, A., Masumoto, N., Gouda, N., Kajitani, K., Shigematsu, H., Emi, A., Kadoya, T., Okada, M.: Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy. Jpn J Clin Oncol, 46(4), 303-309, 2016.

23.     Handa, Y.1), Kai, Y.1), Ikeda, T.1), Mukaida, H.1), Egawa, H.2), Kaneko, M2). (1)Department of Surgery, Hiroshima City Asa Hospital, 2)　Department of Pathology, Hiroshima City Asa Hospital): Pulmonary enteric adenocarcinoma. Gen Thorac Cardiovasc Surg, 64(12):749-751, 2016.

24.     Yoshiya, T., Mimae, T., Tsutani, Y., Tsubokawa, N., Sasada, S., Miyata, Y., Kushitani, K., Takeshima, Y., Murakami, S., Ito, H., Nakayama, H., Okada, M.: Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma. Ann Thorac Surg, 102(5), 1668-1673, 2016.

25.     惠美純子，角舎学行，木村優里，郷田紀子，梶谷桂子，重松英朗，舛本法生，春田るみ1)，片岡　健1)，有廣光司2)，香川直樹3)，岡田守人（１）広島大学病院乳腺外科，２)広島大学病院病理診断科，３)香川乳腺クリニック）：Docetaxel followed by FEC療法による術前化学療法を行い病理学的完全奏功が得られた乳腺原発相細胞癌の一例．乳癌の臨床31（5）：423-430，2016．

26.     笹田伸介，田村研治：HER2-PETイメージング検査による乳癌治療薬体内動態の追跡と臨床応用．乳癌の臨床31（1）：29-36，2016．

27.     伊富貴雄太，吉満政義，恵美学，向田秀則，平林直樹，鍵本篤志，金子真弓，多幾山渉：SOX＋Bevacizumab療法が著効しPathological Complete Responseが確認されたS状結腸癌StageⅣの1 例．癌と化学療法43（6）:769 – 772，2016．

28.     徳永友梨恵，尾畑直美，山本裕美，矢野雷太，伊富貴雄太，大毛宏喜：イラストでよくわかる！ドレーン管理の手技. 消化器外科NURSING 2017 春季増刊号　282:28-67, 2017.

29.     半田 良憲1)，原田 洋明2)，山下 芳典2)(1)広島大学呼吸器外科，2)呉医療センター・中国がんセンター　呼吸器外科)：胸腺癌手術9例の臨床的検討．胸部外科69(7)：495-498, 2016．

30.     小林美恵，有廣光司，重松英朗，甲斐佑一郎，郷田紀子，梶谷桂子，恵美純子，舛本法生，角舎学行，岡田守人：免疫組織化学的染色で上皮間葉転換を示した乳腺紡錘細胞癌の1例．乳癌の臨床 2016;31(4):323-330．

31.     槇殿公誉，久保義郎，た水尾哲也，久保田享，槇殿佳子，小川達博，池田純，槇殿敦(槇殿順記念病院)：単孔式腹腔鏡下手術を施行したS状結腸脂肪腫の1例．広島医学69巻5号　433-435　2016．

32.     槇殿公誉，久保義郎，た水尾哲也，久保田享，槇殿佳子，小川達博，池田純，槇殿敦(槇殿順記念病院)：腹腔鏡下副腎摘出術を施行した非機能性副腎皮質癌の1例．広島医学69巻7号　562-565　2016．

33.     槇殿公誉，久保義郎，た水尾哲也，槇殿佳子，広瀬総三，槇殿敦(槇殿順記念病院)：腹腔鏡手術を施行した胃原発calcifying fibrous tumorの1例．手術　70巻9号　1251-1255 2016．

34.     槇殿公誉，久保義郎，た水尾哲也，槇殿佳子，小川達博，池田純，槇殿敦(槇殿順記念病院)：腹腔鏡下に修復した高齢女性発症大腿ヘルニア嵌頓の1例．広島医学69巻9号　654-656 2016．

35.     槇殿公誉，久保義郎，久保田享，た水尾哲也，槇殿佳子，小川達博，池田純，槇殿敦(槇殿順記念病院)：下腿に発生した悪性結節性汗腺腫の1例．広島医学69巻6号 515-518　2016．

36.     槇殿公誉，久保義郎，小川達博，た水尾哲也，槇殿佳子，池田純，槇殿敦(槇殿順記念病院)：緊急腹腔鏡下手術を施行した漿膜下子宮筋腫茎捻転の1例．広島医学　69巻8号　597-600　2016．